The mRNA expression level of CD163 and ARG1 clearly decreased in cancer patients under chemotherapy regardless of the presence of bevacizumab, although bevacizumab accelerated the decrease of ARG1 (Figure 5C–5D). This evidence concerns the gene ARG1 and cancer.